These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Universal peptidomimetics. Ko E; Liu J; Perez LM; Lu G; Schaefer A; Burgess K J Am Chem Soc; 2011 Jan; 133(3):462-77. PubMed ID: 21182254 [TBL] [Abstract][Full Text] [Related]
6. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of enantiomerically pure perhydro-1,4-diazepine-2,5-dione and 1,4-piperazine-2,5-dione derivatives exhibiting potent activity as apoptosis inhibitors. Moure A; Orzáez M; Sancho M; Messeguer A Bioorg Med Chem Lett; 2012 Dec; 22(23):7097-9. PubMed ID: 23079529 [TBL] [Abstract][Full Text] [Related]
8. Minimalist and universal peptidomimetics. Ko E; Liu J; Burgess K Chem Soc Rev; 2011 Aug; 40(8):4411-21. PubMed ID: 21483946 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and inhibition of cancer cell proliferation of (1,3')-bis-tetrahydroisoquinolines and piperazine systems. Aubry S; Pellet-Rostaing S; Fournier Dit Chabert J; Ducki S; Lemaire M Bioorg Med Chem Lett; 2007 May; 17(9):2598-602. PubMed ID: 17317166 [TBL] [Abstract][Full Text] [Related]
10. Synthetic study of VLA-4/VCAM-1 inhibitors: synthesis and structure-activity relationship of piperazinylphenylalanine derivatives. Saku O; Ohta K; Arai E; Nomoto Y; Miura H; Nakamura H; Fuse E; Nakasato Y Bioorg Med Chem Lett; 2008 Feb; 18(3):1053-7. PubMed ID: 18160288 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues. Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and anticancer activity of piperazine hydroxamates and their histone deacetylase (HDAC) inhibitory activity. Chetan B; Bunha M; Jagrat M; Sinha BN; Saiko P; Graser G; Szekeres T; Raman G; Rajendran P; Moorthy D; Basu A; Jayaprakash V Bioorg Med Chem Lett; 2010 Jul; 20(13):3906-10. PubMed ID: 20605448 [TBL] [Abstract][Full Text] [Related]
13. One-step cyclization: synthesis of N-heteroalkyl-N'-tosylpiperazines. Huang J; Xu W; Xie H; Li S J Org Chem; 2012 Sep; 77(17):7506-11. PubMed ID: 22849619 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of Three-Dimensional (Di)Azatricyclododecene Scaffold and Its Application to Peptidomimetics. Umedera K; Morita T; Yoshimori A; Yamada K; Katoh A; Kouji H; Nakamura H Chemistry; 2021 Aug; 27(46):11888-11894. PubMed ID: 34060167 [TBL] [Abstract][Full Text] [Related]
15. One-pot synthesis and antiproliferative activity of novel 2,4-diaminopyrimidine derivatives bearing piperidine and piperazine moieties. Ma WF; Yang HK; Hu MJ; Li Q; Ma TZ; Zhou ZZ; Liu RY; You WW; Zhao PL Eur J Med Chem; 2014 Sep; 84():127-34. PubMed ID: 25016234 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and analysis of the conformational preferences of 5-aminomethyloxazolidine-2,4-dione scaffolds: first examples of β(2)- and β(2, 2)-homo-Freidinger lactam analogues. Greco A; Tani S; De Marco R; Gentilucci L Chemistry; 2014 Oct; 20(41):13390-404. PubMed ID: 25182659 [TBL] [Abstract][Full Text] [Related]
18. Design, syntheses, and characterization of piperazine based chemokine receptor CCR5 antagonists as anti prostate cancer agents. Arnatt CK; Adams JL; Zhang Z; Haney KM; Li G; Zhang Y Bioorg Med Chem Lett; 2014 May; 24(10):2319-23. PubMed ID: 24731275 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and preliminary evaluation of α-sulfonyl γ-(glycinyl-amino)proline peptidomimetics as matrix metalloproteinase inhibitors. Zhang J; Li X; Jiang Y; Feng J; Li X; Zhang Y; Xu W Bioorg Med Chem; 2014 Jun; 22(11):3055-64. PubMed ID: 24755524 [TBL] [Abstract][Full Text] [Related]